{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Research Triangle Park",
      "state": "NC",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "69959",
      "recalling_firm": "Eisai Inc",
      "address_1": "900 Davis Drive",
      "address_2": "N/A",
      "postal_code": "27709",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-0302-2015",
      "product_description": "BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.",
      "product_quantity": "121,680 bottles",
      "reason_for_recall": "Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.",
      "recall_initiation_date": "20141205",
      "center_classification_date": "20141216",
      "termination_date": "20150521",
      "report_date": "20141224",
      "code_info": "Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15."
    }
  ]
}